Showing results (211-220 of 293) with videos related to
Sort By:
Pageof 30
Cancer Research|December 22, 2018
Activation of Peroxisome Proliferator-Activated Receptors α and δ Synergizes with Inflammatory Signals to Enhance Adoptive Cell TherapySamuel D Saibil, Michael St Paul, Robert C Laister, et al.Nature Medicine|April 28, 2009
Adjuvant IL-7 antagonizes multiple cellular and molecular inhibitory networks to enhance immunotherapiesMarc Pellegrini, Thomas Calzascia, Alisha R Elford, et al.Oncoimmunology|May 15, 2024
Characterization of innate lymphoid cell subsets infiltrating melanoma and epithelial ovarian tumorsDouglas C Chung, Maryam Ghaedi, Kathrin Warner, et al.Journal of Immunology (Baltimore, Md. : 1950)|September 9, 2005
NF-kappaB couples protein kinase B/Akt signaling to distinct survival pathways and the regulation of lymphocyte homeostasis in vivoRussell G Jones, Sam D Saibil, Joyce M Pun, et al.Journal of Immunology (Baltimore, Md. : 1950)|October 30, 2019
Malt1 Protease Deficiency in Mice Disrupts Immune Homeostasis at Environmental Barriers and Drives Systemic T Cell-Mediated AutoimmunityKea Martin, Ratiba Touil, Yeter Kolb, et al.Mucosal Immunology|March 16, 2024
PD-1 regulates ILC3-driven intestinal immunity and homeostasisNicolas Jacquelot, Le Xiong, Wang H J Cao, et al.Genes & Development|March 26, 2003
Essential role for caspase 8 in T-cell homeostasis and T-cell-mediated immunityLeonardo Salmena, Benedicte Lemmers, Anne Hakem, et al.Oncoimmunology|November 20, 2019
Tumor cell expression of B7-H4 correlates with higher frequencies of tumor-infiltrating APCs and higher CXCL17 expression in human epithelial ovarian cancerHeather L MacGregor, Carlos Garcia-Batres, Azin Sayad, et al.Molecular and Cellular Biology|August 18, 2006
Generation and characterization of B7-H4/B7S1/B7x-deficient miceWoong-Kyung Suh, Seng Wang, Gordon S Duncan, et al.Therapeutic Advances in Medical Oncology|October 30, 2025
A retrospective analysis exploring the association of pretreatment neutrophil-to-lymphocyte ratio and immune checkpoint inhibitor outcomes in patients with advanced NSCLC and liver metastasesMaisam Makarem, Tuan Hoang, Mitchell J Elliott, et al.Pageof 30